Insulin Resistance and the IGF-I-Cortical Bone Relationship in Children Ages 9 to 13 Years

Joseph M Kindler1, Norman K Pollock2, Emma M Laing1

  • 1Department of Foods and Nutrition, The University of Georgia, Athens, GA, USA.

Insights

Insulin resistance may hinder insulin-like growth factor-I (IGF-I)

Area of Science:

  • Pediatric Endocrinology
  • Skeletal Biology
  • Metabolic Health

Background:

  • Insulin-like growth factor-I (IGF-I) is crucial for pediatric bone and lean mass development.
  • The impact of insulin resistance on IGF-I's role in cortical bone accrual in children is not well understood.
  • Previous research suggests insulin resistance may affect IGF-I's influence on total body lean and bone mass.

Purpose of the Study:

  • To investigate how insulin resistance affects the relationship between IGF-I and cortical bone geometry in children.
  • To examine if lean mass mediates the association between IGF-I and cortical bone, and if this is influenced by insulin resistance.

Main Methods:

  • Cross-sectional study of early adolescent boys and girls (ages 9-13) categorized by high or normal insulin resistance (HOMA-IR).
  • Peripheral quantitative computed tomography (pQCT) measured tibial cortical bone; dual-energy X-ray absorptiometry (DXA) measured fat-free soft tissue mass (FFST).
  • Fasting sera analyzed for IGF-I, insulin, and glucose; HOMA-IR calculated.

Main Results:

  • Children with high HOMA-IR exhibited greater unadjusted IGF-I levels.
  • Insulin resistance (HOMA-IR) negatively predicted cortical bone area (Ct.Ar) and strength (pSSI).
  • IGF-I positively predicted bone outcomes, but this relationship was moderated by HOMA-IR; FFST mediated the IGF-I-bone relationship, with a weaker indirect effect in high HOMA-IR children.

Conclusions:

  • Insulin resistance may suppress the beneficial effects of IGF-I on cortical bone development in children.
  • The lean mass-dependent pathway linking IGF-I to cortical bone accrual is attenuated in the presence of high insulin resistance.
  • Further prospective studies are warranted to confirm these findings and elucidate mechanisms.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
973
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.1K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.3K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.8K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.8K